Skip to main content
Decorative image for Follow Our Progress page banner

Follow Our Progress

Presentations

Preclinical development of RAG1-40-31L: A novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer. (Abstract)

By June 7, 2023December 1st, 2023No Comments
PUBLICATIONS & PRESENTATIONS

Preclinical development of RAG1-40-31L: A novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer. (Abstract)

Event: 2023 American Society of Clinical Oncology Meeting (Chicago)

View Abstract